MGI Pharma MOGN New patents, anti cancer Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MGI Pharma MOGN New patents, anti cancer

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: tuck who wrote (1622)	12/8/2005 3:02:46 PM
From: Icebrg	Read Replies (1) of 1826

>>Did they confirm my suspicion that Dacogen will get a Class II review? I'd better listen to that darn presentation.>> No, I don't think he said so. (Although at times I was listening with half an ear only). Mulder was as always very expansive. The target is to become one a billion a year company. Erik

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next